Advertising, Promotions, and Related First Amendment Concerns: Part 2 Exploring the Subtleties and Safe Zones of Off-Label Communications

September 21, 2023 11:00am

Joel Kurtzberg
Cahill Gordon and Reindel LLP (New York, NY)

  • Clarifying FDA’s current position on First Amendment and off-label promotion
    • The 21st Century Cures Act
    • FDAMA 114
  • What to expect concerning proposed legislation, rules changes and Citizen Petitions
  • Cases and controversies: state AG actions and private tort claims